Notes And Other Explanatory Information [Abstract]

Xspray Pharma - Filing #679275

Concept 2023-01-01 to
2023-12-31
Notes and other explanatory information [abstract]
Disclosure of accounting judgements and estimates [text block]
*
Disclosure of accrued expenses and other liabilities [text block]
*
Disclosure of auditors' remuneration [text block]
*
Disclosure of authorisation of financial statements [text block]
De finansiella rapporterna för Xspray Pharma*
Disclosure of basis of consolidation [text block]
*
Disclosure of basis of preparation of financial statements [text block]
*
Disclosure of cash and cash equivalents [text block]
*
Disclosure of collateral [text block]
*
Disclosure of commitments and contingent liabilities [text block]
*
Disclosure of credit risk [text block]
*
Disclosure of deferred income [text block]
*
Disclosure of depreciation and amortisation expense [text block]
Disclosure of earnings per share [text block]
*
Disclosure of effect of changes in foreign exchange rates [text block]
*
Disclosure of employee benefits [text block]
*
Disclosure of events after reporting period [text block]
*
Disclosure of expenses [text block]
*
Disclosure of expenses by nature [text block]
Disclosure of finance cost [text block]
*
Disclosure of finance income (cost) [text block]
*
Disclosure of finance income [text block]
*
Disclosure of financial instruments [text block]
*
Disclosure of financial risk management [text block]
*
Disclosure of first-time adoption [text block]
Koncernens finansiella rapporter har upprättats*<
Disclosure of general and administrative expense [text block]
*
Disclosure of general information about financial statements [text block]
Därtill följer koncernredovisningen*
Disclosure of going concern [text block]
Bolaget bedömer att koncernens likvida medel*
Disclosure of impairment of assets [text block]
Nedskrivningstestet utgår ifrån prognostiserade*
Disclosure of income tax [text block]
*
Disclosure of information about employees [text block]
Not 7 Anställda och personalkostnader*<
Disclosure of information about key management personnel [text block]
*
Disclosure of intangible assets [text block]
*
Disclosure of intangible assets and goodwill [text block]
*
Disclosure of interests in other entities [text block]
Moderbolaget, kSEK 2023-12-31 2022-12-31<
Disclosure of information about interim financial reporting [text block]
Finansiell kalender 2024 Datum*<
Disclosure of inventories [text block]
*
Disclosure of investment property [text block]
*
Disclosure of issued capital [text block]
*
Disclosure of lease prepayments [text block]
Framtida leasingbetalningar uppgår till:*
Disclosure of leases [text block]
*
Disclosure of liquidity risk [text block]
*
Disclosure of market risk [text block]
*
Disclosure of material accounting policy information [text block]
Valuta och rapporteringsvalutaModerbolagets funktionella valuta*
Disclosure of other assets [text block]
*
Disclosure of other current assets [text block]
*
Disclosure of other current liabilities [text block]
*
Disclosure of other liabilities [text block]
*
Disclosure of other non-current assets [text block]
*
Disclosure of other operating expense [text block]
*
Disclosure of other operating income (expense) [text block]
*
Disclosure of other operating income [text block]
*
Disclosure of prepayments and other assets [text block]
*
Disclosure of profit (loss) from operating activities [text block]
*
Disclosure of property, plant and equipment [text block]
*
Disclosure of related party [text block]
Not 25 Transaktioner med närstående*<
Disclosure of research and development expense [text block]
Kritiska uppskattningar och bedömningar*<
Disclosure of share capital, reserves and other equity interest [text block]
*
Disclosure of share-based payment arrangements [text block]
IncitamentsprogramBolaget har per*<
Disclosure of subsidiaries [text block]
Namn Kapitalandel*
Disclosure of trade and other payables [text block]
Disclosure of trade and other receivables [text block]
*

Talk to a Data Expert

Have a question? We'll get back to you promptly.